Magnus Schou

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Magnus Schou är adjungerad professor i medicinsk radiokemi vid
institutionen för klinisk neurovetenskap, Karolinska Institutet.

Artiklar

Article: ANGEWANDTE CHEMIE INTERNATIONAL EDITION. 2020;59(32):13490-13495
Transition-Metal-Free Carbon Isotope Exchange of Phenyl Acetic Acids
Destro G; Horkka K; Loreau O; Buisson D-A; Kingston L; Del Vecchio A; Schou M; Elmore CS; Taran F; Cantat T; Audisio D
Article: ACS CHEMICAL NEUROSCIENCE. 2020;11(12):1756-1761
Synthesis and Preclinical Evaluation of 6-[¹⁸F]Fluorine-α- methyl-L-tryptophan, a Novel PET Tracer for Measuring Tryptophan Uptake
Krasikova R; Kondrashov M; Avagliano C; Petukhov M; Vazquez-Romero A; Revunov E; Johnstrom P; Tari L; Toth M; Haggkvist J; Erhardt S; Cervenka S; Schou M
Article: EJNMMI RESEARCH. 2020;10(1):59
Quantification and reliability of [¹¹C]VC-002 binding to muscarinic acetylcholine receptors in the human lung - a test-retest PET study in control subjects
Cselenyi Z; Jucaite A; Kristensson C; Stenkrona P; Ewing P; Varrone A; Johnstrom P; Schou M; Vazquez-Romero A; Moein MM; Bolin M; Siikanen J; Gryback P; Larsson B; Halldin C; Grime K; Eriksson UG; Farde L
Article: ACS CHEMICAL NEUROSCIENCE. 2020;11(9):1245-1249
First Radiolabeling of a Ganglioside with a Positron Emitting Radionuclide: In Vivo PET Demonstrates Low Exposure of Radiofluorinated GM1 in Non-human Primate Brain
Revunov E; Johnstrom P; Arakawa R; Malmquist J; Jucaite A; Defay T; Takano A; Schou M
Article: ACS CHEMICAL NEUROSCIENCE. 2020;11(7):1048-1057
Synthesis, Biodistribution, and Radiation Dosimetry of a Novel mGluR5 Radioligand: ¹⁸F-AZD9272
Nag S; Varnas K; Arakawa R; Jahan M; Schou M; Farde L; Halldin C
Article: JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. 2020;40(4):799-807
A PET study in healthy subjects of brain exposure of ¹¹C-labelled osimertinib - A drug intended for treatment of brain metastases in non-small cell lung cancer
Varrone A; Varnas K; Jucaite A; Cselenyi Z; Johnstrom P; Schou M; Vazquez-Romero A; Moein MM; Halldin C; Brown AP; Vishwanathan K; Farde L
Article: JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS. 2020;63(3):100-107
"In-loop" carbonylation-A simplified method for carbon-11 labelling of drugs and radioligands
Ferrat M; Dahl K; Halldin C; Schou M
Article: JOURNAL OF ORGANIC CHEMISTRY. 2019;84(24):16076-16085
Visible-Light-Enabled Aminocarbonylation of Unactivated Alkyl Iodides with Stoichiometric Carbon Monoxide for Application on Late-Stage Carbon Isotope Labeling
Sardana M; Bergman J; Ericsson C; Kingston LP; Schou M; Dugave C; Audisio D; Elmore CS
Article: EJNMMI RESEARCH. 2019;9(1):100
Potential for imaging the high-affinity state of the 5-HT_1B receptor: a comparison of three PET radioligands with differing intrinsic activity
Lindberg A; Arakawa R; Nogami T; Nag S; Schou M; Elmore CS; Farde L; Pike VW; Halldin C
Article: NUCLEAR MEDICINE AND BIOLOGY. 2019;78-79:11-16
Development of a ¹⁸F-labeled PET radioligand for imaging 5-HT_1B receptors: [¹⁸F]AZ10419096
Lindberg A; Nag S; Schou M; Arakawa R; Nogami T; Moein MM; Elmore CS; Pike VW; Halldin C
Article: JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS. 2019;62(6):265-279
Synthesis, ³H-labelling and in vitro evaluation of a substituted dipiperidine alcohol as a potential ligand for chemokine receptor 2
Artelsmair M; Miranda-Azpiazu P; Kingston L; Bergare J; Schou M; Varrone A; Elmore CS
Article: NUCLEAR MEDICINE AND BIOLOGY. 2019;70:1-13
Synthesis and evaluation of two new candidate high-affinity full agonist PET radioligands for imaging 5-HT_1β receptors
Lindberg A; Lu S; Nag S; Schou M; Liow J-S; Zoghbi SS; Frankland MP; Gladding RL; Morse CL; Takano A; Amini N; Elmore CS; Lee YS; Innis RB; Halldin C; Pike VW
Article: CHEMISTRYSELECT. 2019;4(6):1846-1849
Rapid and Efficient Synthesis of ¹¹C-Labeled Benzimidazolones Using [¹¹C]Carbon Dioxide
Horkka K; Dahl K; Bergare J; Elmore CS; Halldin C; Schou M
Article: EJNMMI RESEARCH. 2019;9(1):9
Pulmonary PET imaging confirms preferential lung target occupancy of an inhaled bronchodilator
Schou M; Ewing P; Cselenyi Z; Friden M; Takano A; Halldin C; Farde L
Article: EJNMMI RESEARCH. 2018;8(1):113
The development of a GPR44 targeting radioligand [¹¹C]AZ12204657 for in vivo assessment of beta cell mass
Jahan M; Johnstrom P; Selvaraju RK; Svedberg M; Winzell MS; Bernstrom J; Kingston L; Schou M; Jia Z; Skrtic S; Johansson L; Korsgren O; Farde L; Halldin C; Eriksson O
Article: ACS CHEMICAL NEUROSCIENCE. 2018;9(11):2542-2547
Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug Strategy
Cairns AG; Vazquez-Romero A; Moein MM; Aden J; Elmore CS; Takano A; Arakawa R; Varrone A; Almqvist F; Schou M
Article: ANGEWANDTE CHEMIE INTERNATIONAL EDITION. 2018;57(31):9744-9748
Late-Stage Isotopic Carbon Labeling of Pharmaceutically Relevant Cyclic Ureas Directly from CO₂
Del Vecchio A; Caille F; Chevalier A; Loreau O; Horkka K; Halldin C; Schou M; Camus N; Kessler P; Kuhnast B; Taran F; Audisio D
Article: ACS CHEMICAL NEUROSCIENCE. 2018;9(5):906-911
Development of [Carbonyl-¹¹C]AZ13198083, a Novel Histamine Type-3 Receptor Radioligand with Favorable Kinetics
Dahl K; Nakao R; Amini N; Moein MM; Finnema S; Malmquist J; Varnas K; Schou M
Article: CHEMICAL COMMUNICATIONS. 2018;54(34):4286-4289
[¹⁸F]fluoro-benziodoxole: a no-carrier-added electrophilic fluorinating reagent. Rapid, simple radiosynthesis, purification and application for fluorine-18 labelling
Gonzalez MAC; Nordeman P; Gomez AB; Meyer DN; Antoni G; Schou M; Szabo KJ
Article: ACS CHEMICAL NEUROSCIENCE. 2018;9(2):224-229
Discovery of a Novel Muscarinic Receptor PET Radioligand with Rapid Kinetics in the Monkey Brain
Malmquist J; Varnas K; Svedberg M; Vallee F; Albert JS; Finnema SJ; Schou M
Article: JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS. 2017;60(13):624-628
Reduction of [¹¹C]CO₂ to [¹¹C]CO using solid supported zinc
Dahl K; Ulin J; Schou M; Halldin C
Article: NUCLEAR MEDICINE AND BIOLOGY. 2017;54:34-40
[¹¹C]AZ10419096-a full antagonist PET radioligand for imaging brain 5-HT_1B receptors
Lindberg A; Nag S; Schou M; Takano A; Matsumoto J; Amini N; Elmore CS; Farde L; Pike VW; Haildin C
Article: JOURNAL OF FLUORINE CHEMISTRY. 2017;194:51-57
Synthesis of trifluoromethyl moieties by late-stage copper (I) mediated nucleophilic fluorination
Gome AB; Gonzalez MAC; Lubcke M; Johansson MJ; Schou M; Szabo KJ
Article: CHEMICAL COMMUNICATIONS. 2016;52(97):13963-13966
Efficient DBU accelerated synthesis of ¹⁸F-labelled trifluoroacetamides
Gomez AB; Gonzalez MAC; Lubcke M; Johansson MJ; Halldin C; Szabo KJ; Schou M
Article: JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 2016;358(3):464-471
Integrated Strategy for Use of Positron Emission Tomography in Nonhuman Primates to Confirm Multitarget Occupancy of Novel Psychotropic Drugs: An Example with AZD3676
Varnas K; Jureus A; Johnstrom P; Ahlgren C; Schott P; Schou M; Gruber S; Jerning E; Malmborg J; Halldin C; Afzelius L; Farde L
Article: EUROPEAN JOURNAL OF ORGANIC CHEMISTRY. 2016;2016(16):2775-2777
Direct and Efficient (Carbonyl)cobalt-Mediated Aryl Acetylation Using [¹¹C] Methyl Iodide
Dahl K; Schou M; Halldin C
Article: ACS CHEMICAL NEUROSCIENCE. 2016;7(2):177-184
Discovery and Preclinical Validation of [¹¹C]AZ13153556, a Novel Probe for the Histamine Type 3 Receptor
Schou M; Varnas K; Jureus A; Ahlgren C; Malmquist J; Haggkvist J; Tari L; Wesolowski SS; Throner SR; Brown DG; Nilsson M; Johnstrom P; Finnema SJ; Nakao R; Amini N; Takano A; Farde L
Article: JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS. 2015;58(5):220-225
An evaluation of a high-pressure ¹¹CO carbonylation apparatus
Dahl K; Itsenko O; Rahman O; Ulin J; Sjoberg C-O; Sandblom P; Larsson L-A; Schou M; Halldin C
Article: INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2015;18(10):pyv036
Large Variation in Brain Exposure of Reference CNS Drugs: a PET Study in Nonhuman Primates
Schou M; Varnas K; Lundquist S; Nakao R; Amini N; Takano A; Finnema SJ; Halldin C; Farde L
Article: RSC ADVANCES. 2015;5(108):88886-88889
¹¹C-carbonylation reactions using gas-liquid segmented microfluidics
Dahl K; Schou M; Ulin J; Sjoberg C-O; Farde L; Halldin C
Article: EJNMMI RESEARCH. 2014;4(1):50-8
Identification of positron emission tomography (PET) tracer candidates by prediction of the target-bound fraction in the brain
Friden M; Wennerberg M; Antonsson M; Sandberg-Stall M; Farde L; Schou M
Article: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 2014;98:140-143
Determination of plasma protein binding of positron emission tomography radioligands by high-performance frontal analysis
Amini N; Nakao R; Schou M; Halldin C
Article: MOLECULAR IMAGING AND BIOLOGY. 2014;16(2):173-179
Synthesis, Radiolabeling, and In Vivo Pharmacokinetic Evaluation of the Amyloid Beta Radioligand [¹¹C]AZD4694 in Nonhuman Primates
Schou M; Varnas K; Sandell J; Johnstrom P; Cselenyi Z; Svensson S; Nakao R; Amini N; Bergman L; Sumic A; Gulyas B; Lindstrom-Boo E; Halldin C; Farde L
Article: EUROPEAN JOURNAL OF ORGANIC CHEMISTRY. 2014;2014(2):307-310
Improved Yields for the Palladium-Mediated ¹¹C-Carbonylation Reaction Using Microwave Technology
Dahl K; Schou M; Rahman O; Halldin C
Article: NUCLEAR MEDICINE AND BIOLOGY. 2013;40(3):410-414
Radiolabeling of the cannabinoid receptor agonist AZD1940 with carbon-11 and PET microdosing in non-human primate
Schou M; Varnas K; Jucaite A; Gulyas B; Halldin C; Farde L
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2013;40(4):580-593
Low background and high contrast PET imaging of amyloid-β with [¹¹C]AZD2995 and [¹¹C]AZD2184 in Alzheimer's disease patients
Forsberg A; Jureus A; Cselenyi Z; Eriksdotter M; Freund-Levi Y; Jeppsson F; Swahn B-M; Sandell J; Julin P; Schou M; Andersson J; Johnstrom P; Varnas K; Halldin C; Farde L; Svensson S
Article: EUROPEAN JOURNAL OF ORGANIC CHEMISTRY. 2013;2013(7):1228-1231
Palladium-Mediated [¹¹C]Carbonylation at Atmospheric Pressure: A General Method Using Xantphos as Supporting Ligand
Dahl K; Schou M; Amini N; Halldin C
Article: ANALYTICAL AND BIOANALYTICAL CHEMISTRY. 2013;405(4):1303-1310
Identification of PET radiometabolites by cytochrome P450, UHPLC/Q-ToF-MS and fast radio-LC: applied to the PET radioligands [¹¹C]flumazenil, [¹⁸F]FE-PE2I, and [¹¹C]PBR28
Amini N; Nakao R; Schou M; Halldin C
Article: JOURNAL OF CHROMATOGRAPHY A. 2012;1266:76-83
Rapid metabolite analysis of positron emission tomography radioligands by direct plasma injection combining micellar cleanup with high submicellar liquid chromatography with radiometric detection
Nakao R; Schou M; Halldin C
Article: JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS. 2012;55(13):460-462
Radiolabeling of two 11C-labeled formylating agents and their application in the preparation of [11C]benzimidazole
Schou M; Halldin C
Article: JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS. 2012;55(13):455-459
Radiofluorination and reductive amination using a microfluidic device
Dahl K; Schou M; Halldin C
Article: BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS. 2012;22(13):4332-4337
Synthesis and evaluation of pyridylbenzofuran, pyridylbenzothiazole and pyridylbenzoxazole derivatives as ¹⁸F-PET imaging agents for β-amyloid plaques
Swahn B-M; Sandell J; Pyring D; Bergh M; Jeppsson F; Jureus A; Neelissen J; Johnstrom P; Schou M; Svensson S
Article: JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2012;895:116-122
Rapid and sensitive measurement of PET radioligands in plasma by fast liquid chromatography/radiometric detection
Nakao R; Schou M; Halldin C
Article: ANALYTICAL CHEMISTRY. 2012;84(7):3222-3230
Direct Plasma Metabolite Analysis of Positron Emission Tomography Radioligands by Micellar Liquid Chromatography with Radiometric Detection
Nakao R; Schou M; Halldin C
Article: JOURNAL OF NUCLEAR MEDICINE. 2012;53(3):415-424
Clinical Validation of ¹⁸F-AZD4694, an Amyloid-β-Specific PET Radioligand
Cselenyi Z; Jonhagen ME; Forsberg A; Halldin C; Julin P; Schou M; Johnstrom P; Varnas K; Svensson S; Farde L
Article: JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS. 2011;54(14):847-854
Synthesis of a delta opioid agonist in [2H6], [2H4], [11C], and [14C] labeled forms
Elmore CS; Brush K; Schou M; Palmer W; Dorff PN; Powell ME; Hoesch V; Hall JE; Hudzik T; Halldin C; Dantzman CL
Article: SYNAPSE. 2009;63(10):871-880
In Vitro Autoradiography and In Vivo Evaluation in Cynomolgus Monkey of [¹⁸F]FE-PE2I, a New Dopamine Transporter PET Radioligand
Varrone A; Steiger C; Schou M; Takano A; Finnema SJ; Guilloteau D; Gulyas B; Halldin C
Article: BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS. 2009;19(16):4843-4845
Synthesis, radiolabeling and preliminary in vivo evaluation of [¹⁸F]FE-PE2I, a new probe for the dopamine transporter
Schou M; Steiger C; Varrone A; Guilloteau D; Halldin C
Article: JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS. 2009;52(5-6):158-165
A two-step one-pot radiosynthesis of the potent dopamine D₂/D₃ agonist PET radioligand [¹¹C]MNPA
Steiger C; Finnema SJ; Raus L; Schou M; Nakao R; Suzuki K; Pike VW; Wikstrom HV; Halldin C
Article: MOLECULAR IMAGING AND BIOLOGY. 2009;11(1):23-30
Investigation of the Metabolites of (S,S)-[¹¹C] MeNER in Humans, Monkeys and Rats
Schou M; Zoghbi SS; Shetty HU; Shchukin E; Liow J-S; Hong J; Andree BA; Gulyas B; Farde L; Innis RB; Pike VW; Halldin C
Article: JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS. 2008;51(3-4):146-152
Radiolabeling of a high potency cannabinoid subtype-1 receptor ligand, N-(4-fluoro-benzyl)-4-(3-(piperidin-1-yl)-indole-1-sulfonyl)benzamide (PipISB), with carbon-11 or fluorine-18
Donohue SR; Halldin C; Schou M; Hong J; Phebus L; Chernet E; Hitchcock SA; Gardinier KM; Ruley KM; Krushinski JH; Schaus J; Pike VW
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2008;35(3):630-636
Biodistribution and radiation dosimetry of the norepinephrine transporter radioligand (S,S)-[¹⁸F]FMeNER-D₂:: a human whole-body PET study
Takano A; Halldin C; Varrone A; Karlsson P; Sjoeholm N; Stubbs JB; Schou M; Airaksinen AJ; Tauscher J; Gulyas B
Article: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2008;35(1):153-157
Imaging the norepinephrine transporter with positron emission tomography:: initial human studies with (S,S)-[¹⁸F]FMeNER-D₂
Takano A; Gulyas B; Varrone A; Karlsson P; Schou M; Airaksinen AJ; Vandenhende F; Tauscher J; Halldin C
Article: APPLIED RADIATION AND ISOTOPES. 2007;65(3):293-300
Synthesis of ³H-labeled N-(3-iodoprop-2E-enyl)-2β-carbomethoxy-3β(4-methylphenyl)nortropane (PE2I) and its interaction with mice striatal membrane fragments
Stepanov V; Schou M; Jarv J; Halldin C
Article: BIOORGANIC AND MEDICINAL CHEMISTRY. 2007;15(2):616-625
Synthesis of ¹¹C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET
Schou M; Pike VW; Sovago J; Gulyas B; Gallagher PT; Dobson DR; Walter MW; Rudyk H; Farde L; Halldin C
Article: JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS. 2006;49(11):1007-1019
Synthesis and PET evaluation of (R)-[S-methyl-¹¹C]thionisoxetine, a candidate radioligand for imaging brain norepinephrine transporters
Schou M; Pike VW; Varrone A; Gulyas B; Farde L; Halldin C
Article: PSYCHOPHARMACOLOGY. 2006;188(1):119-127
Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion:: a PET study in nonhuman primate brain using (S,S)-[¹⁸F]FMeNER-D₂
Seneca N; Gulyas B; Varrone A; Schou M; Airaksinen A; Tauscher J; Vandenhende F; Kielbasa W; Farde L; Innis RB; Halldin C
Article: MOLECULAR IMAGING AND BIOLOGY. 2006;8(1):1-8
Synthesis and positron emission tomography evaluation of three norepinephrine transporter radioligands:: [C-11]desipramine, [C-11]talopram and [C-11]talsupram
Schou M; Sóvágó J; Pike VW; Gulyás B; Bogeso KP; Farde L; Halldin C
Article: BRAIN RESEARCH BULLETIN. 2005;67(3):219-224
Lack of effect of reserpine-induced dopamine depletion on the binding of the dopamine-D3 selective radioligand, [¹¹C]RGH-1756
Sóvágó J; Farde L; Halldin C; Schukin E; Schou M; Laszlovszky I; Kiss B; Gulyás B
Article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2005;15(5):517-520
Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[¹⁸F]FMeNER-D₂
Schou M; Halldin C; Pike VW; Mozley PD; Dobson D; Innis RB; Farde L; Hall H
Article: NUCLEAR MEDICINE COMMUNICATIONS. 2005;26(8):695-700
Whole-body biodistribution, radiation dosimetry estimates for the PET norepinephrine transporter probe (S,S)-[¹⁸F]FMeNER-D₂ in non-human primates
Seneca N; Andree B; Sjoholm N; Schou M; Pauli S; Mozley PD; Stubbs JB; Liow JS; Sovago J; Gulyás B; Innis R; Halldin C
Article: SYNAPSE. 2005;56(2):100-104
Specific in vitro binding of (S,S)-[³H]MeNER to norepinephrine transporters
Ghose S; Fujita M; Morrison P; Uhl G; Murphy DL; Mozley PD; Schou M; Halldin C; Innis R
Article: JOURNAL OF ORGANIC CHEMISTRY. 2004;69(25):8694-8701
A total synthesis of hydroxylysine in protected form and investigations of the reductive opening of p-methoxybenzylidene acetals.
Gustafsson T; Schou M; Almqvist F; Kihlberg J
Article: SYNAPSE. 2004;53(2):57-67
PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain
Schou M; Halldin C; Sóvágó J; Pike VW; Hall H; Gulyás B; Mozley PD; Dobson D; Shchukin E; Innis RB; Farde L
Article: NUCLEAR MEDICINE AND BIOLOGY. 2003;30(7):707-714
Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[¹¹C]MeNER
Schou M; Halldin C; Sóvágó J; Pike VW; Gulyás B; Mozley PD; Johnson DP; Hall H; Innis RB; Farde L
Visa fler

Alla övriga publikationer

Review: TRAC. TRENDS IN ANALYTICAL CHEMISTRY. 2019;110:1-7
Sample preparation techniques for radiometabolite analysis of positron emission tomography radioligands; trends, progress, limitations and future prospects
Moein MM; Nakao R; Amini N; Abdel-Rehim M; Schou M; Halldin C
Review: CLINICAL AND TRANSLATIONAL IMAGING. 2017;5(3):291-298
PET microdosing of CNS drugs
Schou M; Varnas K
Review: CLINICAL AND TRANSLATIONAL IMAGING. 2017;5(3):275-289
New methodologies for the preparation of carbon-11 labeled radiopharmaceuticals
Dahl K; Halldin C; Schou M
Review: CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2007;7(18):1806-1816
Development of radioligands for imaging of brain norepinephrine transporters In Vivo with positron emission tomography
Schou M; Pike VW; Halldin C
Thesis / dissertation: 2006
Synthesis and evaluation of new PET radioloigands for imaging central norepinephrine transporters
Schou, Magnus

Anställningar

Adjungerad Professor, Klinisk neurovetenskap, Karolinska Institutet, 2022-2026

Examina och utbildning

Docent, Medicinsk strålningsbiologi, Karolinska Institutet, 2020
MEDICINE DOKTORSEXAMEN, Institutionen för klinisk neurovetenskap, Karolinska Institutet, 2006

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI